Medullary thyroid carcinoma, familial, 155240, Autosomal dominant; MTC (Familial medullary thyroid carcinoma) (NTRK1 gene) (Sequence Analysis-All Coding Exons) (Postnatal)
- GTR Test IDHelpEach Test is a specific, orderable test from a particular laboratory, and is assigned a unique GTR accession number. The format is GTR00000001.1, with a leading prefix 'GTR' followed by 8 digits, a period, then 1 or more digits representing the version. When a laboratory updates a registered test, a new version number is assigned.: GTR000582080.1
- Last updated: 2020-05-19
- Annual Review past due read more
- Test version history
- 582080.1, last updated: 2020-05-19
Clinical testHelpIn the U.S., clinical tests must be performed under CLIA certification. When a lab uses the same methods for a test in both clinical and research settings, the test appears as two separate GTR records. for Familial medullary thyroid carcinoma
Offered by Intergen
- NCI PDQ, Endocrine and Neuroendocrine Neoplasia geneticsGenetics of Endocrine and Neuroendocrine Neoplasias (PDQ®): Health Professional Version
- NCI PDQ, Cancer Genetics CounselingCancer Genetics Risk Assessment and Counseling (PDQ®): Health Professional Version
- NICE, 2022UK NICE Guideline NG230, Thyroid cancer: assessment and management
- EuroGenetest, 2011Clinical utility gene card for: multiple endocrine neoplasia type 2.
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.